Research reactors in Canada and the Netherlands will work together to create a dual supply of the medical isotope iodine-125 (I-125), McMaster University and NRG have announced. The collaboration is a response to a worldwide shortage of the product in 2017.
Iodine-125 has a half-life of 60 days and is used in brachytherapy for prostate and brain cancers, as well as in diagnostics and radioimmunoassays.
To read more please visit:
Source: World nuclear news